A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy
3 Articles
3 Articles
New dual-drug strategy blocks triple-negative breast cancer growth
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.
A 'one-two punch' against aggressive breast cancer could offer an alternative to chemotherapy
Triple-negative breast cancer (TNBC) has a frustrating ability to adapt. Although this aggressive form of breast cancer can initially respond well to chemotherapy, cancer cells often find ways to survive, allowing the disease to return and become resistant to treatment.
Although triple-negative breast cancer usually responds well to the early assaults of chemotherapy, malignant cells have a desperate ability to adapt, survive and return to the battlefield, this time with greater resistance to drug treatment. That’s why it’s one of the most aggressive variants and with the worst prognosis. To combat this, a team from the South Carolina Medical University (MUSC) has discovered one of the mechanisms behind this re…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
